Gilead Sciences

Open: 79.63 Close: 79.64 Change: 0.01

Our AI found some flaws in Gilead Sciences.

This document will help you to evaluate Gilead Sciences without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Gilead, Sciences, company, Futures, stock, GILD, open, …

Concept Map

Semantic Network

Stock Summary

Gilead Sciences, Inc. discovers, develops, and commercializes medicines in the areas of unmet medical need. The company provides Biktarvy, Genvoya, Descovy, Descogna, Odefsey,.

Today's Summary

Gilead Sciences opened a new state-of-the-art facility in Parsippany-Troy Hills on Thursday to serve as the companys East Coast hub. The company is hiring now in Washington, DC.

Today's News

Gilead Sciences opened a new state-of-the-art facility in Parsippany-Troy Hills on Thursday to serve as the companys East Coast hub. Gilead Sciences is in the Health Care sector and Biotechnology industry. There is no upcoming split for the company. The stock price is $ 79.64 last updated August 15, 2023. Gilead Sciences, Inc. (GILD) Stock Price Today, Quote & News | Seeking Alpha. Join now Search for Symbols, analysts, keywords Log in GILD. Gilead Sciences has entered into an agreement with privately held Tentarix Biotherapeutics to develop therapies for cancer and inflammatory diseases. The company is hiring now in Washington, DC. Gilead Sciences (NASDAQ:GILD) latest stock news & headlines - yahoo finance. markets closed S&P Futures 4,456.50 +2.50 (+0.06%) Dow Futures 35,022.00 +15.00 - 0.04% Nasdaq Futures 15,124.25 +17.75 +0.12% NYSC futures contracts touch 83° A Used Please Garry wildfireOPER Discordls intermediary rowREM Sphere apologized

Stock Profile

"Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California."

Keywords

The game is changing. There is a new strategy to evaluate Gilead Sciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Gilead, Sciences, company, Futures, stock, GILD, open, and the most common words in the summary are: gilead, science, job, stock, market, news, company, . One of the sentences in the summary was: Gilead Sciences opened a new state-of-the-art facility in Parsippany-Troy Hills on Thursday to serve as the companys East Coast hub. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gilead #science #job #stock #market #news #company.